APS: Star Wars 'A Decade or More Away'

Editor's Note: On April 23, the American Physical Society released the findings of a special study group on the science and technology of directed energy weapons such as those proposed in the Strategic Defense Initiative. The 424-page report concludes that the technology for these weapon systems would have to improve by factors of 100 to 1 million or more before they would perform acceptably. The following excerpts are taken from the executive summary and first chapter of the report. The Ameri

Written byAps Study Group
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The APS charged the Study Group to pro duce an unclassified report, which would provide the membership of the Society, other scientists and engineers, as well as a wider interested audience, with basic technological information about DEW. It is hoped that this report, detailing the current state of the art and the future potential of DEW for strategic defense purposes, will serve as a technical reference point for better-informed public discussions on issues relating to the Strategic Defense Initiative.

We estimate that all existing candidates for directed energy weapons (DEWs) require two or more orders of magnitude, (powers of 10) improvements in power output and beam quality before they may be seriously considered for application in ballistic missile defense systems. In addition, many supporting technologies such as space power, beam control and delivery, sensing, tracking, and discrimination need similar improvements over current performance levels before DEWs could be considered for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies